National Academies Press: OpenBook
« Previous: 10 Convergence of Science and Policy to Create a Call for Action
Suggested Citation:"References." Institute of Medicine. 2011. The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science. Washington, DC: The National Academies Press. doi: 10.17226/13033.
×

References

Calver, A. D., A. A. Falmer, M. Murray, O. J. Strauss, E. M. Streicher, M. Hanekom, T. Liversage, M. Masibi, P. D. van Helden, R. M. Warren, and T. C. Victor. 2010. Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerging Infectious Diseases 16(2):264-271.

Chen, M. 2010. MDR-TB Control and Prevention in China. Speaker presentation at the Institute of Medicine Workshop on The New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective, May 26, Moscow, Russian Federation.

Dimitrova, B., A. Hutchings, R. Atun, F. Drobniewski, G. Marchenko, S. Zakharova, I. Fedorin, and R. J. Coker. 2005. Increased risk of tuberculosis among health care workers in Samara Oblast, Russia: Analysis of notification data. International Journal of Tuberculosis and Lung Disease 9(1):43-48.

Frolova, O. 2010. Drug-Resistant Tuberculosis in HIV Patients. Speaker presentation at the Institute of Medicine Workshop on The New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective, May 26, Moscow, Russian Federation.

Gelmanova, I. Y., S. Keshavjee, V. T. Golubchikova, V. I. Berezina, A. K. Strelis, G. V. Yanova, S. Atwood, and M. Murray. 2007. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: Non-adherence, default and the acquisition of multidrug resistance. Bulletin of the World Health Organization 85(9):703-711.

Global Alliance for TB Drug Development. 2010. TB Alliance portfolio. http://www.tballiance.org/downloads/mediakit/TBA_Portfolio_%202.4.2011.pdf (accessed February 14, 2011).

Golubchikov, P., S. Mishustin, and G. Yanova. 2010. MDR Tuberculosis in People with Drug and Alcohol Dependencies: Tomsk Oblast. Speaker presentation at the Institute of Medicine Workshop on The New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective, May 26, Moscow, Russian Federation.

Hanekom, M., G. D. van der Spuy, E. Streicher, S. L. Ndabambi, C. R. McEvoy, M. Kidd, N. Beyers, T. C. Victor, P. D. van Helden, and R. M. Warren. 2007. A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. Journal of Clinical Microbiology 45(5):1483-1490.

Suggested Citation:"References." Institute of Medicine. 2011. The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science. Washington, DC: The National Academies Press. doi: 10.17226/13033.
×

Hoek, K G., H. S. Schaaf, N. C. Gey van Pittius, P. D. van Helden, and R. M. Warren. 2009. Resistance to pyrazinamide and ethambutol compromises MDR/XDR-TB treatment. South African Medical Journal 99(11):785-787.

IOM (Institute of Medicine). 2009. Addressing the threat of drug-resistant tuberculosis: A realistic assessment of the challenge: Workshop summary. Washington, DC: The National Academies Press.

IOM. 2011. The emerging threat of drug-resistant tuberculosis in Southern Africa: Global and local challenges and solutions: Workshop summary. Washington, DC: The National Academies Press.

Johnson, R., A. M. Jordaan, L. Pretorius, E. Engelke, G. van der Spuy, C. Kewley, M. Bosman, P. D. van Helden, R. Warren, and T. C. Victor. 2006. Ethambutol resistance testing by mutation detection. International Journal of Tuberculosis and Lung Disease 10(1):68-73.

Keshavjee, S., and K. Seung. 2008. Stemming the tide of multidrug-resistant tuberculosis: Major barriers to addressing the growing epidemic. http://www.iom.edu/~/media/Files/Activity%20Files/Research/DrugForum/IOM_MDRTB_whitepaper_2009_01_14_FINAL_Edited.pdf (accessed August 30, 2010).

Kuzmin, A. V., I. A. Vasileva, and L. N. Chernousova. 2006. Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the “TB-Biochip” test system. Probl Tuberk Bolezn Legk (8):17-23.

Li, R. 2010. Surveillance for Anti-Tuberculosis Drug Resistance in China. Speaker presentation at the Institute of Medicine Workshop on The New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective, May 26, Moscow, Russian Federation.

Llerena, C., S. E. Fadul, M. C. Garzón, G. Mejía, D. L. Orjuela, L. M. García, H. B. Álvarez, and F. J. Ruiz. 2010. Drug-resistant Mycobacterium tuberculosis in children under 15 years. Biomedica 30(3):362-370.

Louw, G. E., R. M. Warren, P. R. Donald, M. B. Murray, M. Bosman, P. D. Van Helden, D. B. Young, and T. C. Victor. 2006. Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. International Journal of Tuberculosis and Lung Disease 10(7):802-807.

Mlambo, C. K., R. M. Warren, X. Poswa, T. C. Victor, A. G. Duse, and E. Marais. 2008. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. International Journal of Tuberculosis and Lung Disease 12(1):99-104.

Morozova, T. I. 2008 (unpublished). Experience of MDR TB treatment in Saratov region. Presented at 1st Scientific Practical Conference “Problems of diagnostics and treatment of MDR and XDR tuberculosis,” Central Institute for Tuberculosis, Russian Academy of Medical Sciences, December 18-19, 2008.

Mphahlele, M., H. Syre, H. Valvatne, R. Stavrum, T. Mannsåker, T. Muthivhi, K. Weyer, P. B. Fourie, and H. M. Grewal. 2008. Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates. Journal of Clinical Microbiology 46(10):3459-3464.

Nardell, E., B. McGinnis, B. Thomas, and S. Weidhaas. 1986. Exogenous reinfection with tuberculosis in a shelter for the homeless. New England Journal of Medicine 315:1570-1575.

Nugent, R., E. Back, and A. Beith. 2010. The race against drug resistance: A report of the Center for Global Development’s Drug Resistance Working Group. http://www.cgdev.org/content/publications/detail/1424207/ (accessed August 19, 2010).

Perelman, M. I. 2000. Tuberculosis in Russia. International Journal of Tuberculosis and Lung Disease 4(12):1097-1103.

PIH (Partners In Health). 2010. Socios En Salud project history. http://www.pih.org/pages/peru-history# (accessed August 31, 2010).

Suggested Citation:"References." Institute of Medicine. 2011. The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science. Washington, DC: The National Academies Press. doi: 10.17226/13033.
×

Safonova, S. 2010. Epidemiological Indicators for Tuberculosis in Russia’s Penal Institutions (2000-2009). Speaker presentation at the Institute of Medicine Workshop on The New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective, May 26, Moscow, Russian Federation.

Skachkova, E. 2010. The Russian Federation’s National MDR TB Surveillance System. Speaker presentation at the Institute of Medicine Workshop on The New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective, May 26, Moscow, Russian Federation.

Streicher, E. M., R. M. Warren, C. Kewley, J. Simpson, N. Rastogi, C. Sola, G. D. van der Spuy, P. D. van Helden, and T. C. Victor. 2004. Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa. Journal of Clinical Microbiology 42(2):891-894.

van der Spuy, G. D., K. Kremer, S. L. Ndabambi, N. Beyers, R. Dunbar, B. J. Marais, P. D. van Helden, and R. M. Warren. 2009. Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics. Tuberculosis (Edinburgh, Scotland) 89(2):120-125.

WHO (World Health Organization). 1996. Groups at risk: WHO report on the tuberculosis epidemic. Geneva, Switzerland: WHO.

WHO. 2006. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva, Switzerland: WHO.

WHO. 2008. Anti-tuberculosis drug resistance in the world, report no. 4: The World Health Organization (WHO)/International Union Against Tuberculosis and Lung Disease (IUATLD) Global Project on Anti-Tuberculosis Drug Resistance Surveillance 2002-2007. Geneva, Switzerland: WHO.

WHO. 2009. Global tuberculosis control: Epidemiology, strategy, financing. Geneva, Switzerland: WHO.

WHO. 2010a. 2010/2011 tuberculosis global facts. http://www.who.int/tb/publications/2010/factsheet_tb_2010.pdf (accessed February 8, 2011).

WHO. 2010b. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. Geneva, Switzerland: WHO. http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf (accessed August 18, 2010).

WHO. 2010c. Global tuberculosis control: WHO Report 2010. Annex 2: Global, regional and country-specific data for key indicators. Geneva, Switzerland: WHO.

WHO. 2010d. Factsheet: Tuberculosis diagnostics automated DNA test. http://www.who.int/tb/features_archive/new_rapid_test/en/index.html (accessed December 29, 2010).

Willingham F. F., T. L. Schmitz, M. Contreras, S. E. Kalangi, A. M. Vivar, L. Caviedes, E. Schiantarelli, P. M. Neumann, C. Bern, and R. H. Gilman. 2001. Working Group on TB in Peru. Hospital control and multidrug-resistant pulmonary tuberculosis in female patients, Lima, Peru. Emerging Infectious Diseases 7(1):123-127.

Wright, A., M. Zignol, A. Van Deun, D. Falzon, S. R. Gerdes, K. Feldman, S. Hoffner, F. Drobniewski, L. Barrera, D. van Soolingen, F. Boulabhal, C. N. Paramasivan, K. M. Kam, S. Mitarai, P. Nunn, M. Raviglione, and Global Project on Anti-Tuberculosis Drug Resistance Surveillance. 2009. Epidemiology of antituberculosis drug resistance 2002-07: An updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 373(9678):1861-1873.

Yakimova, M. 2010. The Epidemiology of Tuberculosis in Russia. Speaker presentation at the Institute of Medicine Workshop on The New Profile of Drug-Resistant Tuberculosis: A Global and Local Perspective, May 26, Moscow, Russian Federation.

Suggested Citation:"References." Institute of Medicine. 2011. The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science. Washington, DC: The National Academies Press. doi: 10.17226/13033.
×

This page intentionally left blank.

Suggested Citation:"References." Institute of Medicine. 2011. The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science. Washington, DC: The National Academies Press. doi: 10.17226/13033.
×
Page 109
Suggested Citation:"References." Institute of Medicine. 2011. The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science. Washington, DC: The National Academies Press. doi: 10.17226/13033.
×
Page 110
Suggested Citation:"References." Institute of Medicine. 2011. The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science. Washington, DC: The National Academies Press. doi: 10.17226/13033.
×
Page 111
Suggested Citation:"References." Institute of Medicine. 2011. The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science. Washington, DC: The National Academies Press. doi: 10.17226/13033.
×
Page 112
Next: Appendix A: Agenda »
The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop by the Institute of Medicine and the Russian Academy of Medical Science Get This Book
×
Buy Paperback | $38.00 Buy Ebook | $30.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

An estimated 2 billion people, one third of the global population, are infected with Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Spread through the air, this infectious disease killed 1.7 million in 2009, and is the leading killer of people with HIV. Tuberculosis (TB) is also a disease of poverty--the vast majority of tuberculosis deaths occur in the developing world. Exacerbating the devastation caused by TB is the growing threat of drug-resistant forms of the disease in many parts of the world.

Drug-resistant tuberculosis presents a number of significant challenges in terms of controlling its spread, diagnosing patients quickly and accurately, and using drugs to treat patients effectively. In Russia in recent decades, the rise of these strains of TB, resistant to standard antibiotic treatment, has been exacerbated by the occurrence of social, political, and economic upheavals. The Institute of Medicine (IOM) Forum on Drug Discovery, Development, and Translation, in conjunction with the Russian Academy of Medical Sciences held a workshop to discuss ways to fight the growing threat of drug-resistant TB. The New Profile of Drug-Resistant Tuberculosis in Russia: A Global and Local Perspective: Summary of a Joint Workshop presents information from experts on the nature of this threat and how it can be addressed by exploring various treatment and diagnostic options.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!